Dermaseptin S4 (1-26)

General Information


DRACP ID  DRACP02902

Peptide Name   Dermaseptin S4 (1-26)

Sequence  ALWMTLLKKVLKAAAKAALNAVLVGA

Sequence Length  26

UniProt ID  P80280 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
SW620 Colon adenocarcinoma Carcinoma 42.19±24.29% Cytotoxicity=256 µg/ml MTT assay 3h 1

Hemolytic Activity  Human erythrocytes: 74.2±5.82% Hemolysis=256 µg/ml

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02902

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C125H218N32O29S

Absent amino acids  CDEFHIPQRSY

Common amino acids  A

Mass  311152

Pl  11.28

Basic residues  4

Acidic residues  0

Hydrophobic residues  18

Net charge  4

Boman Index  3033

Hydrophobicity  117.69

Aliphatic Index  154.23

Half Life 
  Mammalian: 20 hour
  Yeast: 30 min
  E.coli: >10 hour

Extinction Coefficient cystines  5500

Absorbance 280nm  220

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 33774792

Title  Evaluating the effect of dermaseptin S4 and its derivatives on multidrug-resistant bacterial strains and on the colon cancer cell line SW620

Doi 10.1007/s11356-021-13683-2 Abstract

Year  2021

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPS_18030

DRACP is developed by Dr.Zheng's team.